ArticleCardiovascular and interventional radiology2026
Early Single-centre Experience with Semi-Branched Endovascular Aneurysm Repair.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the short-term follow-up experience with treating juxtarenal aortic aneurysm or type 1a endoleak after previous endovascular aneurysm repair (EVAR) by using the novel semi-branched endograft (sBEVAR) (Artivion, Hechingen, Germany).
methodsAll consecutive patients undergoing elective aortic aneurysm repair with the sBEVAR graft from Artivion were retrospectively reviewed from the electronic patient files. Indications for sBEVAR were a juxtarenal or suprarenal aortic aneurysm or type 1a endoleak after previous EVAR, with suitable anatomy for endovascular repair. Primary outcome was technical success, defined as successfully placing the sBEVAR and placing bridging stents in the planned target vessels without type I or III endoleak at the end of the procedure. Any complication during or after the procedure was registered, as well as target vessel patency and any reintervention during the current follow-up.
resultsA total of 21 patients were included in the analysis. Technical success was achieved in 20 patients (95.2%), with acute conversion to open repair in 1 patient due to rupture of the left common iliac artery. A further 4 patients had complications during the procedure. Mean follow-up was 10 ± 5,7 months. Primary target vessel patency was 98.7% during follow-up. Four reintervention procedures were necessary during the follow-up period, with a reintervention-free survival rate of 81.0%. Overall survival was 90.5%.
conclusionThe findings in this retrospective study confirm that sBEVAR using the Artivion design platform is a safe and feasible technique for treating complex aortic aneurysms. The technique achieves a high technical success rate and demonstrates reintervention rates comparable to inner-branched EVAR and fenestrated EVAR.
Indexed as
Identifiers
41266808What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.